Tuesday 7 October 2014

Epic Research Update : Ranbaxy Laboratories

Epic Update Ranbaxy Laboratories

Ranbaxy Laboratories’ wholly owned subsidiary – Ranbaxy Laboratories Inc. (RLI), has launched ABSORICA (isotretinoin) 25mg and 35mg capsules into the US healthcare market. ABSORICA has become the most prescribed branded oral isotretinoin in the US, as per a recent independent survey conducted with dermatologists.



The promoters holding in the company stood at 63.40% while Institutions and Non-Institutions held 20.53% and 13.65% respectively.



Real Time News & Trading Trends Keep Liking #EpicResearch




FacebookTwitterYouTubePinterestLinkedin - Google+



For more information ✆ – 0731-6642300 or Visit http://ift.tt/1k8NnLH


0 comments:

Post a Comment

 
Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Online Project management